(Q73389200)

English

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

scientific article published on 01 June 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744879%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744879%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

immunologic adjuvant

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

molecular medicine

1 reference

10.1016/S0264-410X(03)00045-8

https://api.crossref.org/works/10.1016/S0264-410X(03)00045-8

2 January 2024

Scott A Halperin

1

object named as

Scott A. Halperin

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12744879

2 January 2024

author name string

Gary Van Nest

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744879%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Bruce Smith

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744879%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Simin Abtahi

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744879%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Heather Whiley

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744879%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Joseph J. Eiden

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12744879

2 January 2024

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744879%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

2 June 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12744879

2 January 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0264410X03000458?httpAccept=text/xml

1 reference

10.1016/S0264-410X(03)00045-8

https://api.crossref.org/works/10.1016/S0264-410X(03)00045-8

2 January 2024

https://api.elsevier.com/content/article/PII:S0264410X03000458?httpAccept=text/plain

1 reference

10.1016/S0264-410X(03)00045-8

https://api.crossref.org/works/10.1016/S0264-410X(03)00045-8

2 January 2024

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744879%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744879%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

2461-2467

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744879%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

19-20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744879%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nationwide vaccination: a success story in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hexamer palindromic oligonucleotides with 5'-CG-3' motif(s) induce production of interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Oligodeoxynucleotide modifications determine the magnitude of B cell stimulation by CpG motifs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of human B cells by phosphorothioate oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of 5 and 10 microgram doses of two recombinant hepatitis B vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination against hepatitis B: comparison of three different vaccination schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A hepatitis B vaccine formulated with a novel adjuvant system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis-B Vaccination in the Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The control of hepatitis B virus infection with vaccine in Yupik Eskimos. Demonstration of safety, immunogenicity, and efficacy under field conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine

8

1 reference

10.1016/S0264-410X(03)00045-8

https://api.crossref.org/works/10.1016/S0264-410X(03)00045-8

2 January 2024

CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen

27

1 reference

10.1016/S0264-410X(03)00045-8

https://api.crossref.org/works/10.1016/S0264-410X(03)00045-8

2 January 2024

Identifiers

10.1016/S0264-410X(03)00045-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744879%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744879%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73389200&oldid=2042947605"